Delivering Sarclisa via an under-the-skin injection may improve the quality of life of patients with pretreated relapsed, refractory multiple myeloma, according to recent research. Treatment with ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback